NASDAQ
34.13USD
+2.45 (+7.73%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
1.2B
P/E
—
EPS
—
Beta
3.37
52W range
14.72-49.91
Day range
30.88–34.33
Open
31.28
Prev close
31.68
Volume
982.1K
Avg volume
842.5K
Dividend
0.00
IPO
2026-04-20
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about First Tracks Biotherapeutics Inc — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for TRAX: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
